Business · 15/11/2023Updated: 10/17/2026 · 1 min read

FDA Renews Nonprescription Drugs Advisory Committee Charter for 2 Years

The Food and Drug Administration (FDA) has renewed the Nonprescription Drugs Advisory Committee charter for an additional 2 years, with the new charter set to expire on August 27, 2025, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.